Measurements of thromboxane production and their clinical significance in coronary heart disease

被引:5
作者
Renda, Giulia [1 ]
De Caterina, Raffaele [1 ,2 ]
机构
[1] Univ G DAnnunzio, Inst Cardiol & Ctr Excellence Aging, Pisa, Italy
[2] Fdn G Monasterio, Pisa, Italy
关键词
ASPIRIN; BIOSYNTHESIS; RESISTANCE; 11-DEHYDROTHROMBOXANE-B2; CIRCULATION; DRUGS; TIME;
D O I
10.1160/TH12-05-0311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:6 / 8
页数:3
相关论文
共 24 条
[1]   11-DEHYDROTHROMBOXANE-B2 - A QUANTITATIVE INDEX OF THROMBOXANE-A2 FORMATION IN THE HUMAN CIRCULATION [J].
CATELLA, F ;
HEALY, D ;
LAWSON, JA ;
FITZGERALD, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5861-5865
[2]   Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].
Catella-Lawson, F ;
Reilly, MP ;
Kapoor, SC ;
Cucchiara, AJ ;
DeMarco, S ;
Tournier, B ;
Vyas, SN ;
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817
[3]   Laboratory detection of 'aspirin resistance': what test should we use (if any)? [J].
Cattaneo, Marco .
EUROPEAN HEART JOURNAL, 2007, 28 (14) :1673-1675
[4]   FRACTIONAL CONVERSION OF THROMBOXANE-B2 TO URINARY 11-DEHYDROTHROMBOXANE-B2 IN MAN [J].
CIABATTONI, G ;
PUGLIESE, F ;
DAVI, G ;
PIERUCCI, A ;
SIMONETTI, BM ;
PATRONO, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 992 (01) :66-70
[5]   The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs - Is it time to believe the hype? [J].
Curtis, JP ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :991-993
[6]   Mechanisms of disease:: Platelet activation and atherothrombosis [J].
Davi, Giovanni ;
Patrono, Carlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24) :2482-2494
[7]   Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].
Eikelboom, JW ;
Hirsh, J ;
Weitz, JI ;
Johnston, M ;
Yi, Q ;
Yusuf, S .
CIRCULATION, 2002, 105 (14) :1650-1655
[8]   The genetics of antiplatelet drug resistance [J].
Feher, G. ;
Feher, A. ;
Pusch, G. ;
Lupkovics, G. ;
Szapary, L. ;
Papp, E. .
CLINICAL GENETICS, 2009, 75 (01) :1-18
[9]  
FITZGERALD GA, 1987, FASEB J, V46, P154
[10]   THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].
HAMBERG, M ;
SVENSSON, J ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998